(Q40196652)

18 September 2017

1 reference

title

Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. (English)

1 reference

18 September 2017

1 reference

3

R N Brogden

1 reference

18 September 2017

B Holmes

1

1 reference

18 September 2017

D M Richards

series ordinal

2

1 reference

18 September 2017

R C Heel

series ordinal

4

1 reference

18 September 2017

publication date

1 November 1984

1 reference

18 September 2017

1 reference

18 September 2017

volume

28

1 reference

18 September 2017

issue

5

1 reference

18 September 2017

page(s)

375-425

1 reference

Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin

18 September 2017

cites work

1 reference

12 December 2020

In vitro activity of apalcillin compared with that of other new penicillins and anti-Pseudomonas cephalosporins

1 reference

12 December 2020

The activity of piperacillin against anaerobic bacilli

1 reference

12 December 2020

Synergistic activity of piperacillin in combination with beta-lactamase inhibitors

1 reference

12 December 2020

Inhibition of Cell Division of Escherichia coli by a New Synthetic Penicillin, Piperacillin

1 reference

12 December 2020

In vitro studies of piperacilin, a new semisynthetic penicillin

1 reference

12 December 2020

Comparison of in vitro activity of moxalactam (LY127935) with cefazolin, amikacin, tobramycin, carbenicillin, piperacillin, and ticarcillin against 420 blood culture isolates

1 reference

12 December 2020

Penetration of piperacillin into bronchial mucosa and sputum

1 reference

12 December 2020

Antibiotics in immunosuppressed patients

1 reference

12 December 2020

Comparative susceptibilities of 40 strains of Pseudomonas aeruginosa to 10 antipseudomonal antimicrobial agents.

1 reference

12 December 2020

In-vitro studies with ceftazidime against aerobic gram-negative bacilli and Bacteroides fragilis group.

1 reference

12 December 2020

In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria

1 reference

12 December 2020

Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds

1 reference

12 December 2020

Pharmacokinetics of Ticarcillin in Patients with Abnormal Renal Function

1 reference

12 December 2020

Activities of various beta-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis

1 reference

12 December 2020

Piperacillin: pharmacokinetic studies on the biliary and renal excretion (author's transl)

1 reference

12 December 2020

Comparison of the in-vitro activities of ceftazidime and new cephalosporins against 107 strains of Pseudomonas aeruginosa and 249 strains of cefazolin-resistant Enterobacteriaceae

1 reference

12 December 2020

Piperacillin distribution into bile, gallbladder wall, abdominal skeletal muscle, and adipose tissue in surgical patients

1 reference

12 December 2020

Comparative in vitro activities of beta-lactam-tobramycin combinations against Pseudomonas aeruginosa and multidrug-resistant gram-negative enteric bacilli

1 reference

12 December 2020

Excretion in bile and clinical study of T-1220 (piperacillin) in biliary tract diseases (author's transl)

1 reference

12 December 2020

Pharmacokinetics of azlocillin in subjects with normal and impaired renal function

1 reference

12 December 2020

Piperacillin therapy for serious bacterial infections.

1 reference

12 December 2020

Comparison of the in-vitro activity of Sch 29482 with thirteen other beta-lactam antibiotics against Neisseria meningitidis and Neisseria gonorrhoeae (including penicillinase-producing isolates)

1 reference

12 December 2020

In vitro antimicrobial activity of piperacillin and seven other β-lactam antibiotics against Neisseria gonorrhoeae and Haemophilus influenzae, including β-lactamase producing strains

1 reference

12 December 2020

Clinical evaluation of the therapeutic efficacy and tolerability of piperacillin

1 reference

12 December 2020

Clinical evaluation of piperacillin with observations on penetrability into cerebrospinal fluid

1 reference

12 December 2020

Fundamental studies of transferred concentration of piperacillin into maternal serum, umbilical cord serum and amniotic fluid

1 reference

12 December 2020

In vitro and in vivo activity of piperacillin, a new broad-spectrum semisynthetic penicillin

1 reference

12 December 2020

Carbenicillin-induced haemorrhagic cystitis

1 reference

12 December 2020

Comparative pharmacokinetics of piperacillin in normals and in patients with renal failure

1 reference

12 December 2020

Klebsiella species: antimicrobial susceptibilities, bactericidal kinetics, and in vitro inactivation of beta-lactam agents

1 reference

12 December 2020

Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis

1 reference

12 December 2020

Comparative activity in vitro of piperacillin.

1 reference

12 December 2020

[Susceptibilities of clinical isolates to aminoglycoside antibiotics. Susceptibility of clinical isolates from patients with complex and refractory infections].

1 reference

12 December 2020

In vitro activity of LY127935, a new 1-oxa cephalosporin, against aerobic gram-negative bacilli

1 reference

12 December 2020

Activity of nine antimicrobial agents against Lancefield group C and group G streptococci

1 reference

12 December 2020

Empiric antibiotic therapy for granulocytopenic patients

1 reference

12 December 2020

Piperacillin pharmacokinetics in subjects with chronic renal failure.

1 reference

12 December 2020

Activity and synergy of ureido penicillins and aminoglycosides against Pseudomonas aeruginosa

1 reference

12 December 2020

Carbenicillin administration in patients with severe renal failure

1 reference

12 December 2020

Pharmacokinetics of piperacillin in patients with moderate renal failure and in patients undergoing hemodialysis

1 reference

12 December 2020

Clinical Evaluation of Combination of Cefmetazole and Piperacillin in the Treatment of Infections in Patients with Acute Leukemia

1 reference

12 December 2020

Antibacterial activity and beta-lactamase stability of ceftazidime, an aminothiazolyl cephalosporin potentially active against Pseudomonas aeruginosa

1 reference

12 December 2020

Antigenicity of semisynthetic penicillin preparations to evoke systemic anaphylactic reactions in animal models

1 reference

12 December 2020

Piperacillin: human pharmacokinetics after intravenous and intramuscular administration

1 reference

12 December 2020

Meningitis due to Haemophilus influenzae type e biotype 4

1 reference

12 December 2020

Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis

1 reference

12 December 2020

Sepsis associated with urinary tract infection. Antibiotic treatment with piperacillin

1 reference

12 December 2020

Clinical evaluation of piperacillin therapy for infection.

1 reference

12 December 2020

Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients

1 reference

12 December 2020

In vitro and in vivo antibacterial activity of T-1220, a new semisynthetic penicillin

1 reference

12 December 2020

Clinical evaluation of piperacillin in bronchopulmonary infection

1 reference

12 December 2020

Fundamental and clinical studies on piperacillin in the field of obstetrics and gynecology

1 reference

12 December 2020

Piperacillin: a review of clinical experience

1 reference

12 December 2020

SQ 26,776, a novel beta-lactam: an in-vitro comparison with other antimicrobial agents

1 reference

12 December 2020

In vitro activity of temocillin (BRL 17421), a novel beta-lactam antibiotic

1 reference

12 December 2020

In vitro and in vivo antibacterial effects of combinations of beta-lactam antibiotics

1 reference

12 December 2020

Pharmacokinetics of piperacillin following intravenous administration

1 reference

12 December 2020

Use of piperacillin, a semisynthetic penicillin, in the therapy of acute exacerbations of pulmonary disease in patients with cystic fibrosis

1 reference

12 December 2020

Piperacillin, a new penicillin active against many bacteria resistant to other penicillins

1 reference

12 December 2020

Comparison of mezlocillin, piperacillin, Bay k 4999 with carbenicillin and ticarcillin against enterobacteriaceae and Pseudomonas aeruginosa

1 reference

12 December 2020

A three category system for interpretation of disk tests for Pseudomonas-active penicillins and beta-lactamase hydrolysis/inhibition studies

1 reference

12 December 2020

Penetration of piperacillin into the cerebrospinal fluid of patients with purulent meningitis

1 reference

12 December 2020

Inactivation of aminoglycosides by penicillins

1 reference

12 December 2020

Susceptibilities of anaerobic bacteria to N-formimidoyl thienamycin (MK0787) and to other antibiotics

1 reference

12 December 2020

In Vitro Comparison of N -Formimidoyl Thienamycin, Piperacillin, Cefotaxime, and Cefoperazone

1 reference

12 December 2020

Antibacterial activity of an oral penem, Sch 29482

1 reference

12 December 2020

Effect of clavulanic acid on minimal inhibitory concentrations of 16 antimicrobial agents tested against Legionella pneumophila

1 reference

12 December 2020

A sulfone .BETA.-lactam compound which acts as a .BETA.-lactamase inhibitor

1 reference

12 December 2020

Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine Cephalosporin

1 reference

12 December 2020

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

1 reference

12 December 2020

In-vitro inactivation of aminoglycoside antibiotics by piperacillin and carbenicillin

1 reference

12 December 2020

The effect of piperacillin prophylaxis on the colonic microflora In patients undergoing colorectal surgery

1 reference

12 December 2020

Induction of beta-lactamase by various beta-lactam antibiotics in Enterobacter cloacae

1 reference

12 December 2020

Relevance of in vitro antibacterial activities and pharmacokinetic properties of antipseudomonal beta-lactam antibiotics to their therapeutic effects on urinary tract infection caused by Pseudomonas aeruginosa P 9 in mice

1 reference

12 December 2020

Comparative in vitro activity of N-formimidoyl thienamycin against gram-positive and gram-negative aerobic and anaerobic species and its beta-lactamase stability

1 reference

12 December 2020

Activity of Amikacin, Gentamicin and Schering 21420 when Combined with Carbenicillin or Piperacillin against <i>Pseudomonas aeruginos</i><i>a</i>

1 reference

12 December 2020

In Vitro Activity of Furazlocillin (Bay k 4999) Compared with Those of Mezlocillin, Piperacillin, and Standard Beta-Lactam Antibiotics

1 reference

12 December 2020

Comparative in vitro activity of moxalactam, cefotaxime, cefoperazone, piperacillin, and aminoglycosides against gram-negative bacilli

1 reference

12 December 2020

In vitro antagonism of beta-lactam antibiotics by cefoxitin

1 reference

12 December 2020

Piperacillin pharmacokinetics in pediatric patients

1 reference

12 December 2020

Piperacillin (T-1220), a new semisynthetic penicillin. II. In vitro antimicrobial activity and synergy comparison with carbenicillin and gentamicin

1 reference

12 December 2020

Piperacillin v Carbenicillin in the Therapy for Serious Infections

1 reference

12 December 2020

Pharmacokinetic study of piperacillin in the field of obstetrics and gynecology

1 reference

12 December 2020

Adverse reactions to piperacillin in cystic fibrosis.

1 reference

12 December 2020

Pharmacokinetics of piperacillin in subjects with various degrees of renal function

1 reference

12 December 2020

6 beta-Iodopenicillanic acid (UI-38,006), a beta-lactamase inhibitor that extends the antibacterial spectrum of beta-lactam compounds: initial bacteriological characterization

1 reference

12 December 2020

The in-vitro activity of ceftazidime against clinically important pathogens.

1 reference

12 December 2020

Comparative in vitro appraisal of piperacillin, including its activity against Salmonella typhi

1 reference

12 December 2020

The effect of piperacillin dose on elimination kinetics in renal impairment

1 reference

12 December 2020

In-vitro activity of Sch 29482 against bacterial blood isolates

1 reference

12 December 2020

Activity of semisynthetic penicillins and synergism with mecillinam against Bacteroides species

1 reference

12 December 2020

Comparison of piperacillin and penicillin in the treatment of uncomplicated gonorrhea

1 reference

12 December 2020

Piperacillin in early neonatal infection

1 reference

12 December 2020

Clinical evaluation of piperacillin in the field of obstetrics and gynecology

1 reference

12 December 2020

Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin

1 reference

12 December 2020

Carbenicillin and ticarcillin.

1 reference

12 December 2020

Clinical trial of piperacillin with acquisition of resistance by Pseudomonas and clinical relapse

1 reference

12 December 2020

Piperacillin Plus Amikacin Therapy v Carbenicillin Plus Amikacin Therapy in Febrile, Granulocytopenic Patients

1 reference

12 December 2020

Effects of sodium piperacillin on platelet function in normal volunteers

1 reference

12 December 2020

Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients

1 reference

12 December 2020

Comparative study of parenteral piperacillin and cefoxitin in the treatment of surgical infections of the abdomen.

1 reference

12 December 2020

In vitro susceptibilities of Aeromonas hydrophila against new antibiotics

1 reference

12 December 2020

Evaluation of cefmetazole and piperacillin with or without tobramycin for infections in patients with hematological disorders.

1 reference

12 December 2020

In-vitro activity of cefoperazone and penicillins alone and in combination with aminoglycosides against Pseudomonas aeruginosa

1 reference

12 December 2020

Comparative efficacy of piperacillin and penicillin G in treatment of gonococcal urethritis

1 reference

12 December 2020

Comparison of the In Vitro Activity of Bay k 4999 and Piperacillin, Two New Antipseudomonal Broad-Spectrum Penicillins, with Other β-Lactam Drugs

1 reference

12 December 2020

Bacteriology and treatment of dental infections

1 reference

12 December 2020

Susceptibility of group B streptococci to 16 beta-lactam antibiotics, including new penicillin and cephalosporin derivatives

1 reference

12 December 2020

Pharmacokinetics of intravenously administered piperacillin in preadolescent children

1 reference

12 December 2020

In vitro activity of ceftazidime, cefotaxime and piperacillin against multi-resistant gram-negative bacteria tested with a modified agar dilution method

1 reference

12 December 2020

Piperacillin Sodium (a phase III clinical trial)

1 reference

12 December 2020

Statistical comparison of the antibacterial activities of broad-spectrum penicillins against gram-negative bacilli

1 reference

12 December 2020

In vitro evaluation of Ro 13-9904

1 reference

12 December 2020

Clinical and microbiological evaluation of piperacillin in elective biliary surgery

1 reference

12 December 2020

[Chemotherapy of biliary tract infections. XIV. Biliary excretion and gallbladder tissue levels of piperacillin (author's transl)]

1 reference

12 December 2020

10.2165/00003495-198428050-00002

Identifiers

DOI

1 reference

Dimensions Publication ID

18 September 2017

1010722466

0 references

1 reference